Title: Infliximab for the treatment of Crohn's disease
Subjects: Chemotherapy, Gastrointestinal Agents, Crohn's disease, Monoclonal Antibodies, Drug therapy, Monoclonal antibodies, Cost-Benefit Analysis, Therapeutic use, Treatment Outcome, Crohn Disease